Endoscopy during COVID – what have we learned?

Heiko Pohl

doi:10.1055/a-1327-2386

Endoscopy, Table of Contents

Endoscopy 2021; 53(02): 171-172
DOI: 10.1055/a-1327-2386

Editorial

Endoscopy during COVID – what have we learned?

Referring to Manes G et al. p. 162–165 and Lantinga MA et al. p. 166–170

Heiko Pohl

Section of Gastroenterology, VA Medical Center, White River Junction, Vermont, United States

› Author Affiliations

Abstract

Full Text

References

References
1 Lantinga MA, Theunissen F, ter Borg PCJ. et al. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in the Netherlands: analysis of a prospective endoscopy database. Endoscopy 2021; 23: 166-170
2 Manes G, Saibeni S, Pellegrini L. et al. Improvement in appropriateness and diagnostic yield of fast-track endoscopy during the COVID-19 pandemic in Northern Italy. Endoscopy 2021; 53: 162-165
3 Gralnek IM, Hassan C, Beilenhoff U. et al. ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: an update on guidance during the post-lockdown phase and selected results from a membership survey. Endoscopy 2020; 52: 891-898
4 Rutter MD, Brookes M, Lee TJ. et al. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis. Gut 2020;
5 Sud A, Jones ME, Broggio J. et al. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol 2020; 31: 1065-1074
6 Pohl H, Robertson D, Welch HG. Repeated upper endoscopy in the Medicare population: a retrospective analysis. Ann Intern Med 2014; 160: 154
7 Zorzi M, Senore C, Turrin A. et al. Appropriateness of endoscopic surveillance recommendations in organised colorectal cancer screening programmes based on the faecal immunochemical test. Gut 2016; 65: 1822-1828
8 Kalager M, Wieszczy P, Lansdorp-Vogelaar I. et al. Overdiagnosis in colorectal cancer screening: time to acknowledge a blind spot. Gastroenterology 2018; 155: 592-595